BIOiSIMTM is a first-in-class 'virtual drug development engine' that offers unprecedented value for the drug development industry by narrowing down the number of drug compounds that offer anticipated value for the treatment or cure of specific illness or disease.
“At a time when numerous smaller organizations are over-selling their AI efforts as cure-alls, I found VSL's down-to-earth but competent and insightful approach very refreshing...I would not hesitate to recommend them for organizations looking for professional and knowledgeable external ML solutions.”
We offer a range of translational-based solutions, customized for your pre-clinical and clinical programs. These offerings are all centered around our proven and validated BIOiSIMTM platform for small molecules, large molecules, and viruses.
Our models are built on data from thousands of compounds across 7 species, leading to a robustness rarely seen in the industry.
The BIOiSIMTM platform can be used before preclinical animal trial start, allowing earlier insights and savings in expensive outsourced experimentation.
VSL has shown that the best models are developed by using a hybrid mixed-model approach to drug insights, leading to greater accuracy and scalability.
With a focus on human outcomes, the platform has at its core a translability engine that transforms insights across species.
The team employees a continuous improvement process to iterate on data stability, improve models, and provide an always up-to-date software service.
The flexibility of the platform and generations of customer-ready tools allows for development of custom models and validations within weeks.
BIOiSIMTM enables your team with a novel platform that focuses your development efforts on the drug compounds that are more likely to deliver on the anticipated value for the treatment or cure of a specific disease.
With our framework, we can quickly develop custom, specific models.
Validated with both FDA and proprietary compounds.
We are always adding new functionality and expanding the domain of applicability.
We simulate various routes of administrations such as IV, oral, and transdermal and others.
Our platform is cloud-based and generates predictions in seconds.
Our model extracts conclusions from complex and convoluted data.
Speak to one of our experts today